NEOG - Neogen Corporation
| Previous Close | 71.79 |
| Open | 71.45 |
| Bid | 66.04 x 800 |
| Ask | 73.19 x 900 |
| Day's Range | 69.22 - 72.01 |
| 52 Week Range | 50.60 - 97.38 |
| Volume | 135,927 |
| Avg. Volume | 223,146 |
| Market Cap | 3.639B |
| Beta (3Y Monthly) | 1.11 |
| PE Ratio (TTM) | 60.53 |
| EPS (TTM) | 1.15 |
| Earnings Date | Sep 23, 2019 - Sep 27, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 71.00 |
- Zacks
Neogen Gets AOAC Validation for NeoSeek to Ensure Food Safety
Neogen's (NEOG) proprietary testing platform gets upgraded to reduce the incidence of bacterial contamination in livestock.
- Zacks
Why Is Neogen (NEOG) Up 4.4% Since Last Earnings Report?
Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- PR Newswire
Neogen's NeoSeek™ for STEC receives AOAC validation
LANSING, Mich. , Aug. 21, 2019 /PRNewswire/ -- Neogen Corporation (Nasdaq: NEOG) announced AOAC has validated NeoSeek ™ for STEC, a proprietary testing platform that determines the genetic composition ...
- PR Newswire
Neogen licenses food safety data analytics platform from Corvium
LANSING, Mich. , Aug. 19, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it has signed a development and licensing agreement with Corvium, Inc., that will allow Neogen's customers ...
- Simply Wall St.
Don't Sell Neogen Corporation (NASDAQ:NEOG) Before You Read This
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). We'll apply a...
- Zacks
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Sector ETF report for PSCH
- GuruFocus.com
Neogen Corp (NEOG) President & CEO John Edward Adent Sold $2.2 million of Shares
President & CEO of Neogen Corp (30-Year Financial, Insider Trades) John Edward Adent (insider trades) sold 31,489 shares of NEOG on 08/05/2019 at an average price of $69.03 a share. Continue reading...
- PR Newswire
AOAC approves Neogen's Reveal® Q+ for DON
LANSING, Mich., Aug. 1, 2019 /PRNewswire/ -- Neogen Corporation (NEOG) has received Performance TestedSM Method Certification from the AOAC Research Institute for its Reveal® Q+ for Deoxynivalenol (DON) test, which is designed for the rapid quantification of the mold toxin in grains. The AOAC approval (No. 071901) follows the earlier verification of the test's performance by the USDA's Federal Grain Inspection Service (FGIS). FGIS's approval of Reveal Q+ for DON enabled the simple, fully quantitative lateral flow strip test to be used for testing in the national grain inspection system.
- GuruFocus.com
Neogen Corp (NEOG) Files 10-K for the Fiscal Year Ended on May 31, 2019
Neogen Corp (NEOG) files its latest 10-K with SEC for the fiscal year ended on May 31, 2019. Neogen Corp, through its subsidiaries, develops, manufactures and markets a line of products dedicated to food and animal safety. Continue reading...
- GuruFocus.com
Neogen Corp (NEOG) VP & CFO Steven J. Quinlan Sold $1 million of Shares
VP & CFO of Neogen Corp (30-Year Financial, Insider Trades) Steven J. Quinlan (insider trades) sold 15,000 shares of NEOG on 07/25/2019 at an average price of $69.04 a share. Continue reading...
- Thomson Reuters StreetEvents
Edited Transcript of NEOG earnings conference call or presentation 23-Jul-19 3:00pm GMT
Q4 2019 Neogen Corp Earnings Call
- Zacks
Neogen's (NEOG) Q4 Earnings Beat Estimates, Revenues Miss
Neogen's (NEOG) strong international business and solid performance by core Food Safety segment resulted in year-over-year revenue growth.
- Zacks
Neogen (NEOG) Tops Q4 Earnings Estimates
Neogen (NEOG) delivered earnings and revenue surprises of 7.14% and -1.09%, respectively, for the quarter ended May 2019. Do the numbers hold clues to what lies ahead for the stock?
- PR Newswire
Neogen reports fiscal 2019 results
LANSING, Mich. , July 23, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that revenues for the fourth quarter of its 2019 fiscal year, which ended May 31 , were $109,762,000 , compared ...
- Simply Wall St.
What Should You Know About Neogen Corporation's (NASDAQ:NEOG) Future?
In February 2019, Neogen Corporation (NASDAQ:NEOG) announced its earnings update. Overall, analyst forecasts seem...
- PR Newswire
Neogen awarded USDA contract
LANSING, Mich. , July 22, 2019 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that it had again been awarded the contract to supply certain dehydrated culture media to the U.S. Department ...
- Simply Wall St.
Should You Care About Neogen Corporation’s (NASDAQ:NEOG) Investment Potential?
Today we'll look at Neogen Corporation (NASDAQ:NEOG) and reflect on its potential as an investment. In particular...
- Zacks
Earnings Preview: Neogen (NEOG) Q4 Earnings Expected to Decline
Neogen (NEOG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Markit
See what the IHS Markit Score report has to say about Neogen Corp.
Neogen Corp NASDAQ/NGS:NEOGView full report here! Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is moderate and increasing * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | NeutralShort interest is moderate for NEOG with between 5 and 10% of shares outstanding currently on loan. This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on July 12. Money flowETF/Index ownership | PositiveETF activity is positive. Over the last month, ETFs holding NEOG are favorable, with net inflows of $3.80 billion. Additionally, the rate of inflows is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Consumer Goods sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
- Zacks
Here's Why You Should Hold Onto Neogen (NEOG) Stock Now
Investors' trust continues to be high in Neogen (NEO), thanks to strength in its Food Safety and Genomic businesses.
- Simply Wall St.
Should You Be Adding Neogen (NASDAQ:NEOG) To Your Watchlist Today?
It's only natural that many investors, especially those who are new to the game, prefer to buy shares in 'sexy' stocks...
- Insider Monkey
Is Neogen Corporation (NEOG) A Good Stock To Buy?
Is Neogen Corporation (NASDAQ:NEOG) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research. Hedge funds spend millions of dollars on Ivy League graduates, expert networks, and get tips from investment bankers and industry insiders. Sure they sometimes fail miserably, but their consensus stock picks historically […]
- Zacks
Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?
Sector ETF report for PSCH
